The launch date of Deferasirox dispersible tablets

Deferasirox dispersible tablets (Deferasirox) is a drug used to treat excessive iron load in the body. It is mainly used in patients receiving long-term blood transfusion treatment, such as thalassemia. This drug is an iron attenuator, which helps the body eliminate excess iron load by binding excess iron ions in the body, thereby maintaining iron balance in the body.

Dedeferasirox dispersible tablets were approved for sale in China in 2010 and have been included in medical insurance. Patients can purchase them domestically. The domestic price of 125mg*28 tablets is around 600 to 700. For specific prices and medical insurance reimbursement, please consult the local hospital pharmacy. There are original and generic deferasirox dispersible tablets in foreign countries. The original drug is mainly the Swiss Novartis original drug, and the price of 400mg*30 tablets is around 400 to 500; the generic drugs are mainly Indian generic drugs, and the specification of 400mg*30 tablets is about 300 to 400, and the ingredients of the original drug and generic drugs are basically the same.

The main function of Deferasirox dispersible tablets is to combine with free iron ions to form a stable complex, which is then excreted through urine and bile. This process helps reduce iron accumulation caused by blood transfusions and avoid adverse effects on various organs of the body.

The drug's dispersible tablet form is easier for patients to take orally because it quickly disperses in water, making it easier for patients to take it after or with a meal. This formulation improves patient compliance and helps to better control iron load.

However, when using deferasirox dispersible tablets, patients will need regular blood and urine tests to monitor the effectiveness of the treatment and ensure there are no adverse reactions. The doctor will adjust the dosage according to the patient's specific condition to achieve the best therapeutic effect.

In summary, deferasirox dispersible tablets, as an iron attenuator, play an important role in the treatment of transfusion-related iron overload conditions. However, during use, patients should pay close attention to their doctor's advice and undergo regular examinations to ensure safe and effective management of iron load.